Bone Antiresorptive Therapy With Antiretroviral Initiation Pilot Trial
Phase of Trial: Phase II
Latest Information Update: 25 Apr 2018
Price : $35 *
At a glance
- Drugs Alendronic acid/colecalciferol (Primary)
- Indications Bone disorders; Osteoporosis
- Focus Therapeutic Use
- Acronyms BATARI
- 31 Aug 2018 Biomarkers information updated
- 17 Apr 2018 Status changed from recruiting to completed.
- 15 Apr 2016 Planned End Date changed from 1 Sep 2015 to 1 Aug 2017.